02/14/2024 3:46 PM | GREENLIGHT CAPITAL INC (Filed by) NeuBase Therapeutics, Inc. (Subject) NeuBase Therapeutics (Subject)
| Form SC 13G/A | |
01/26/2024 7:00 AM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/17/2024 5:15 AM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/28/2023 6:00 AM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/28/2023 5:15 AM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form 424B3 | |
12/22/2023 5:15 AM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/20/2023 6:30 AM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
10/18/2023 7:00 AM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/29/2023 3:10 PM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2023 7:42 PM | NeuBase Therapeutics, Inc. (Issuer) NeuBase Therapeutics (Issuer) Shiff Aleta (Reporting) Shiff Barry (Reporting) Symetryx Corp (Reporting)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
09/20/2023 4:28 PM | NeuBase Therapeutics, Inc. (Subject) NeuBase Therapeutics (Subject) Symetryx Corp (Filed by)
| Form SC 13D/A | |
09/18/2023 3:32 PM | NeuBase Therapeutics, Inc. (Issuer) NeuBase Therapeutics (Issuer) Symetryx Corp (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 3:17 PM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/18/2023 3:20 PM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form DEFA14A | |
09/14/2023 5:03 AM | NeuBase Therapeutics, Inc. (Subject) NeuBase Therapeutics (Subject) Symetryx Corp (Filed by)
| Form SC 13D/A | |
09/12/2023 4:20 PM | NeuBase Therapeutics, Inc. (Issuer) NeuBase Therapeutics (Issuer) Shiff Aleta (Reporting) Shiff Barry (Reporting) Symetryx Corp (Reporting)
| Form 3/A | |
09/11/2023 4:08 PM | NeuBase Therapeutics, Inc. (Issuer) NeuBase Therapeutics (Issuer) Symetryx Corp (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/07/2023 4:19 PM | NeuBase Therapeutics, Inc. (Issuer) NeuBase Therapeutics (Issuer) Symetryx Corp (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/01/2023 1:51 PM | NeuBase Therapeutics, Inc. (Issuer) NeuBase Therapeutics (Issuer) Symetryx Corp (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/11/2023 5:18 AM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form DEFA14A | |
08/11/2023 5:20 AM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form ARS | |
08/10/2023 11:15 PM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form EFFECT | |
08/11/2023 5:15 AM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form DEF 14A | |
08/04/2023 3:39 PM | NeuBase Therapeutics, Inc. (Issuer) NeuBase Therapeutics (Issuer) Stephan Dietrich A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 6:05 AM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2023 3:45 PM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form PRE 14A | |
07/31/2023 3:10 PM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/28/2023 5:03 AM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
07/07/2023 3:11 PM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
06/30/2023 3:21 PM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/30/2023 7:41 AM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form 424B3 | |
06/30/2023 7:42 AM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form 424B5 | |
05/22/2023 6:00 AM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/29/2023 4:04 PM | NeuBase Therapeutics, Inc. (Filer) NeuBase Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |